Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 4
2015 6
2016 7
2017 7
2018 3
2019 5
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Dual antiretroviral therapy for HIV infection.
Soriano V, Fernandez-Montero JV, Benitez-Gutierrez L, Mendoza C, Arias A, Barreiro P, Peña JM, Labarga P. Soriano V, et al. Among authors: benitez gutierrez l. Expert Opin Drug Saf. 2017 Aug;16(8):923-932. doi: 10.1080/14740338.2017.1343300. Epub 2017 Jul 11. Expert Opin Drug Saf. 2017. PMID: 28621159 Review.
Hepatitis C cure with antiviral therapy--benefits beyond the liver.
Soriano V, Labarga P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Barreiro P. Soriano V, et al. Among authors: benitez gutierrez l. Antivir Ther. 2016;21(1):1-8. doi: 10.3851/IMP2975. Epub 2015 Jun 25. Antivir Ther. 2016. PMID: 26110692 Review.
Drug interactions with new hepatitis C oral drugs.
Soriano V, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Peña JM. Soriano V, et al. Among authors: benitez gutierrez l. Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):333-41. doi: 10.1517/17425255.2015.998997. Epub 2015 Jan 2. Expert Opin Drug Metab Toxicol. 2015. PMID: 25553890 Review.
Treatment and prevention of HIV infection with long-acting antiretrovirals.
Benítez-Gutiérrez L, Soriano V, Requena S, Arias A, Barreiro P, de Mendoza C. Benítez-Gutiérrez L, et al. Expert Rev Clin Pharmacol. 2018 May;11(5):507-517. doi: 10.1080/17512433.2018.1453805. Epub 2018 Mar 29. Expert Rev Clin Pharmacol. 2018. PMID: 29595351 Review.
Treatment of hepatitis C with new fixed dose combinations.
Soriano V, Fernandez-Montero JV, de Mendoza C, Benitez-Gutierrez L, Peña JM, Arias A, Barreiro P. Soriano V, et al. Among authors: benitez gutierrez l. Expert Opin Pharmacother. 2017 Aug;18(12):1235-1242. doi: 10.1080/14656566.2017.1346609. Epub 2017 Jul 30. Expert Opin Pharmacother. 2017. PMID: 28644739 Review.
Drug interactions in HIV-infected patients treated for hepatitis C.
Soriano V, Labarga P, Fernandez-Montero JV, Mendoza C, Benítez-Gutiérrez L, Peña JM, Barreiro P. Soriano V, et al. Among authors: benitez gutierrez l. Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):807-816. doi: 10.1080/17425255.2017.1351942. Epub 2017 Jul 13. Expert Opin Drug Metab Toxicol. 2017. PMID: 28689442 Review.
HIV-2 and HTLV-1 infections in Spain, a non-endemic region.
de Mendoza C, Caballero E, Aguilera A, Pirón M, Ortiz de Lejarazu R, Rodríguez C, Cabezas T, González R, Treviño A, Soriano V; Spanish HIV-2/HTLV Group. de Mendoza C, et al. AIDS Rev. 2014 Jul-Sep;16(3):152-9. AIDS Rev. 2014. PMID: 25180694 Review.
Prevention and management of treatment failure to new oral hepatitis C drugs.
Benítez-Gutiérrez L, Barreiro P, Labarga P, de Mendoza C, Fernandez-Montero JV, Arias A, Peña JM, Soriano V. Benítez-Gutiérrez L, et al. Expert Opin Pharmacother. 2016 Jun;17(9):1215-23. doi: 10.1080/14656566.2016.1182156. Epub 2016 May 9. Expert Opin Pharmacother. 2016. PMID: 27149603 Review.
30 results